TUBIZE-FIN
Research TUBIZE-FIN (TUB.BR) on Bullrun: market cap EUR 7.99B, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTUB.BR
- ExchangeXBRU
- CountryBelgium
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 7.99B
- Dividend yield0.6%
- Financial periodFY2025
- RevenueEUR 0
- Net incomeEUR 93.23M
- Free cash flow-EUR 3.37M
Valuation Snapshot
latest market cap is EUR 7.99B; dividend yield is 0.6%.
Peer valuation comparison
Latest dividend yield is 0.6% versus a Healthcare sector median of 2.05% (70.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 0 | EUR 93.23M | -EUR 3.37M | n/a | 2.09 | EUR 368.07K | EUR 0 | EUR 1.89B |
| FY2024 | EUR 0 | EUR 90.10M | -EUR 2.07M | n/a | 2.02 | EUR 1.43M | EUR 41.30M | EUR 1.84B |
| FY2023 | EUR 0 | EUR 88.15M | -EUR 2.05M | n/a | 1.98 | EUR 574.84K | EUR 79.20M | EUR 1.80B |
| FY2022 | EUR 0 | EUR 85.17M | -EUR 2.11M | n/a | 1.91 | EUR 1.07M | EUR 47.80M | EUR 1.75B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-23 | EUR 7.99B | n/a | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: yield 0.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.04 EUR |
| FY2024 | 0.97 EUR |
| FY2023 | 0.86 EUR |
| FY2022 | 0.75 EUR |
| FY2021 | 0.68 EUR |
About TUBIZE-FIN
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TUBIZE-FIN's market cap?
TUBIZE-FIN's market capitalization is EUR 7.99B.
Does TUBIZE-FIN pay a dividend?
TUBIZE-FIN has a dividend yield of 0.6%.
What does TUBIZE-FIN do?
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.